SlateStone Wealth’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,563
Closed -$477K 298
2025
Q2
$477K Sell
9,563
-1,180
-11% -$53.3K 0.04% 213
2025
Q1
$317K Buy
10,743
+103
+1% +$3.83K 0.03% 234
2024
Q4
$257K Buy
10,640
+413
+4% +$10.2K 0.03% 258
2024
Q3
$188K Buy
+10,227
New +$183K 0.02% 280
2023
Q3
Sell
-83,980
Closed -$789K 234
2023
Q2
$789K Sell
83,980
-9,050
-10% -$89.7K 0.15% 101
2023
Q1
$923K Buy
+93,030
New +$815K 0.19% 97

Other funds holding HIMS

SlateStone Wealth's HIMS Position: Q3 2025 in Review

SlateStone Wealth sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 9,563 shares — an estimated $477K sold.

SlateStone Wealth first reported a position in HIMS in Q1 2023 and held it in 6 quarters. The position peaked at $923K in Q1 2023. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

  • SlateStone Wealth reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
  • SlateStone Wealth sold 9,563 Hims & Hers Health shares in Q3 2025, an estimated $477K.
  • SlateStone Wealth first reported a position in Hims & Hers Health in Q1 2023 and held it in 6 quarters.
  • SlateStone Wealth's Hims & Hers Health position peaked at $923K in Q1 2023.
  • 512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on SlateStone Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.